Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen

Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen

Bibliografische gegevens
Hoofdauteur:	Coates, L
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	John Wiley & Sons, Ltd. 2017

Gelijkaardige items

Identification of psoriatic arthritis in patients with psoriasis
door: Coates, LC, et al.
Gepubliceerd in: (2023)

Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis
door: Coates, L, et al.
Gepubliceerd in: (2018)

Methotrexate in psoriasis and psoriatic arthritis
door: Coates, L, et al.
Gepubliceerd in: (2020)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
door: Vivekanantham, A, et al.
Gepubliceerd in: (2024)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
door: Coates, L, et al.
Gepubliceerd in: (2016)

Screening/referral strategies for the early recognition of psoriatic arthritis (PsA) among patients with psoriasis: results of a GRAPPA survey
door: Song, K, et al.
Gepubliceerd in: (2023)

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate
door: Coates, LC, et al.
Gepubliceerd in: (2023)

An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areas
door: Coates, L, et al.
Gepubliceerd in: (2016)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
door: Coates, L, et al.
Gepubliceerd in: (2016)

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
door: Alinaghi, F, et al.
Gepubliceerd in: (2018)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
door: Coates, LC, et al.
Gepubliceerd in: (2022)

The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis
door: Frischknecht, L, et al.
Gepubliceerd in: (2019)

Cell and tissue specific functional genomics of psoriasis and psoriatic arthritis
door: Lledo Lara, A
Gepubliceerd in: (2019)

Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial
door: McHugh, N, et al.
Gepubliceerd in: (2024)

Patient perspectives on psoriatic disease burden: results from the global Psoriasis and Beyond survey
door: Armstrong, A, et al.
Gepubliceerd in: (2023)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
door: Palfreeman, A, et al.
Gepubliceerd in: (2013)

Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis
door: Reich, K, et al.
Gepubliceerd in: (2022)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
door: Ogdie, A, et al.
Gepubliceerd in: (2023)

Endomysial antibodies in psoriatic arthritis patients.
door: Dockerty, J, et al.
Gepubliceerd in: (2002)

Tapering and discontinuation of biologics in patients with psoriatic arthritis with low disease activity
door: Ye, W, et al.
Gepubliceerd in: (2018)

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis
door: Singh, J, et al.
Gepubliceerd in: (2018)

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis
door: Singh, J, et al.
Gepubliceerd in: (2018)

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis
door: Singh, JA, et al.
Gepubliceerd in: (2018)

Sustained very low disease activity and remission in psoriatic arthritis patients
door: Lubrano, E, et al.
Gepubliceerd in: (2019)

Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey
door: Richette, P, et al.
Gepubliceerd in: (2022)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology consensus‐based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis
door: Coates, L, et al.
Gepubliceerd in: (2017)

Psoriatic arthritis
door: FitzGerald, O, et al.
Gepubliceerd in: (2021)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
door: Poddubnyy, D, et al.
Gepubliceerd in: (2021)

Psoriatic arthritis: prospects for the future
door: Hackett, S, et al.
Gepubliceerd in: (2022)

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
door: Dougados, M, et al.
Gepubliceerd in: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
door: Helliwell, PS, et al.
Gepubliceerd in: (2023)

The road to personalised medicine in psoriatic arthritis
door: White, JPE, et al.
Gepubliceerd in: (2021)

Clinical, genetic and omics-based biomarkers that might support the identification of the development of psoriatic arthritis in individuals with psoriasis – a narrative review of the literature
door: Grohmann, T, et al.
Gepubliceerd in: (2024)

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis
door: Helliwell, P, et al.
Gepubliceerd in: (2018)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
door: Coates, LC, et al.
Gepubliceerd in: (2022)

Measuring outcomes in psoriatic arthritis
door: Ogdie, A, et al.
Gepubliceerd in: (2020)

The effect of tofacitinib on residual pain in patients with psoriatic arthritis
door: Dougados, M, et al.
Gepubliceerd in: (2020)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
door: Helliwell, PS, et al.
Gepubliceerd in: (2021)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
door: Perrotta, FM, et al.
Gepubliceerd in: (2024)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
door: Gladman, DD, et al.
Gepubliceerd in: (2022)